Clinical Research in Oncology

New Partnership with Myeloma Canada

Myeloma Canada and the Quebec –  Clinical Research Organization in Cancer (Q-CROC) are pleased to announce their new partnership to optimize support for those affected by myeloma.

Every day, 11 Canadians are diagnosed with myeloma and despite its increasing prevalence, little is known about this cancer. Although there is no cure, patients are living better and longer thanks to the development of new treatments. However, a cure for myeloma requires more investment and research.

“Q-CROC is pleased to work with Myeloma Canada, a national non-profit organization created by and for people affected by multiple myeloma. By working together, our two organizations will raise awareness and improve access to myeloma clinical trials in Quebec. – Lucie D’Amours, General Manager of Q-CROC

“Since its very beginning, Myeloma Canada has been committed to accompanying its community through every step of their journey. By collaborating with select partners such as Q-CROC, we ensure that our members have access to all the resources available to help them make decisions when the time comes for them to consider participating in a clinical trial. – Martine Elias, Executive Director of Myeloma Canada

Visit the Myeloma Canada website to learn more about myeloma:

Did you know?
In Quebec, about 15 clinical trials are currently open in Montreal, Quebec City and Longueuil. About 10 people living with myeloma took part in a clinical trial in 2022. Increased participation in clinical research is essential to support the development of tomorrow’s treatments and provide a better understanding of the disease. To find out which clinical trials are recruiting participants in Quebec, visit

Share on Facebook
Share on Linkedin